Related Experiment Video
Updated: Jul 5, 2025

Resin-Assisted Capture Coupled with Isobaric Tandem Mass Tag Labeling for Multiplexed Quantification of Protein Thiol Oxidation
Published on: June 21, 2021
Targeting Cysteine Oxidation in Thrombotic Disorders
Moua Yang1, Roy L Silverstein2,3
1Division of Hemostasis and Thrombosis, Beth Israel Deaconess Medical Center, Harvard Medical School, 3 Blackfan Circle, CLS-924, Boston, MA 02115, USA.
Oxidative stress promotes thrombosis via cysteine oxidation. This review explores mechanisms involving CD36 and protein disulfide isomerase (PDI), highlighting therapeutic targets for limiting blood clots.
Area of Science:
- Biochemistry
- Molecular Biology
- Hematology
Background:
- Oxidative stress is linked to increased thrombotic events, but the precise prothrombotic mechanisms remain elusive.
- Cysteine residues in proteins are susceptible to oxidation, potentially altering protein function and contributing to disease.
- Understanding these mechanisms is crucial for developing effective antithrombotic strategies.
Purpose of the Study:
- To review the role of cysteine oxidation in oxidative stress-related thrombosis.
- To highlight key signaling pathways involving CD36 and protein disulfide isomerase (PDI).
- To discuss current and future therapeutic approaches targeting cysteine oxidation.
Main Methods:
- Literature review focusing on cysteine reactivity, oxidation, and thrombosis.
- Analysis of recent findings on specific proteins like CD36 and PDI in the context of oxidative stress and thrombosis.
- Discussion of antioxidative and chemical biology strategies.
Main Results:
- Cysteine oxidation is a significant factor in how oxidants promote thrombosis.
- The CD36 signaling pathway in dyslipidemia and the role of protein disulfide isomerase (PDI) are key areas of focus.
- Targeting cysteine modifications presents a potential therapeutic avenue.
Conclusions:
- Cysteine oxidation plays a critical role in the prothrombotic effects of oxidative stress.
- Further research into CD36 and PDI pathways is needed to fully elucidate these mechanisms.
- Targeting oxidative cysteine modifications offers promising strategies for thrombosis prevention.
More Related Videos
09:37Combining Non-reducing SDS-PAGE Analysis and Chemical Crosslinking to Detect Multimeric Complexes Stabilized by Disulfide Linkages in Mammalian Cells in Culture
Published on: May 2, 2019
11:25Targeting Cysteine Thiols for in Vitro Site-specific Glycosylation of Recombinant Proteins
Published on: October 4, 2017
Related Concept Videos
Anticoagulant Drugs: Low-Molecular-Weight Heparins
Disorders of Hemostasis
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
Preparation and Reactions of Thiols
Electron Transport Chain: Complex I and II
ROS generation is regulated and maintained at moderate levels necessary...
Phase II Reactions: Glutathione Conjugation and Mercapturic Acid Formation
Several distinctive characteristics distinguish glutathione conjugation from other phase II...
Electron Transport Chain: Complex III and IV